MBX Biosciences, Inc.
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 86.11% | 82.73% | 42.55% | 41.37% | 306.98% |
| Total Receivables | 261.83% | 127.94% | 210.85% | 80.42% | 412.80% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 70.78% | 210.21% | 32.89% | 40.98% | -5.17% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 146.61% | 30.03% | 7.22% | 5.25% | 95.04% |
| Total Current Assets | 86.68% | 83.62% | 42.75% | 41.37% | 289.77% |
|
|
|||||
| Total Current Assets | 86.68% | 83.62% | 42.75% | 41.37% | 289.77% |
| Net Property, Plant & Equipment | 225.38% | 124.13% | 168.72% | 113.90% | 78.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,125.49% | 1,058.00% | 666.00% | 0.00% | -98.18% |
| Total Assets | 88.28% | 84.08% | 43.42% | 41.67% | 268.18% |
|
|
|||||
| Total Accounts Payable | -24.43% | 64.29% | -44.20% | -24.67% | 78.95% |
| Total Accrued Expenses | 218.98% | 21.44% | 122.65% | 41.52% | 21.58% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 357.25% | 36.92% | 0.58% | -7.23% | -14.81% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 101.26% | 38.98% | 40.21% | 10.46% | 43.40% |
|
|
|||||
| Total Current Liabilities | 101.26% | 38.98% | 40.21% | 10.46% | 43.40% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 429.30% | -- | -- | 965.91% | 488.51% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -95.65% | -95.24% | -89.71% | -88.00% |
| Total Liabilities | 114.69% | 42.28% | 43.52% | 13.65% | 46.05% |
|
|
|||||
| Common Stock & APIC | 73.95% | 72.99% | 50.27% | 50.01% | 6,672.03% |
| Retained Earnings | -57.68% | -53.67% | -63.25% | -66.02% | -74.22% |
| Treasury Stock & Other | -11,209.09% | -1,243.40% | 420.00% | 45.28% | 173.33% |
| Total Common Equity | 86.80% | 85.95% | 43.42% | 42.81% | 323.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 86.80% | 85.95% | 43.42% | 42.81% | 323.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 86.80% | 85.95% | 43.42% | 42.81% | 302.48% |
|
|
|||||